Publications

Detailed Information

Novel loss-of-function variants of TRAPPC2 manifesting X-linked spondyloepiphyseal dysplasia tarda: report of two cases

DC Field Value Language
dc.contributor.authorWon, Joon Yeon-
dc.contributor.authorKim, Dayeon-
dc.contributor.authorPark, Seon Young-
dc.contributor.authorLee, Hye Ran-
dc.contributor.authorLim, Jong-Seok-
dc.contributor.authorPark, Jong Hoon-
dc.contributor.authorSong, Mi Hyun-
dc.contributor.authorSong, Hae Ryong-
dc.contributor.authorKim, Ok-Hwa-
dc.contributor.authorKim, Yonghwan-
dc.contributor.authorCho, Tae-Joon-
dc.date.accessioned2019-06-10T08:23:41Z-
dc.date.available2019-06-10T17:28:57Z-
dc.date.issued2019-05-03-
dc.identifier.citationBMC Medical Genetics. 20(1):70ko_KR
dc.identifier.issn1471-2350-
dc.identifier.urihttps://hdl.handle.net/10371/153829-
dc.description.abstractBackground
X-linked spondyloepiphyseal dysplasia tarda (SEDT-XL) is a skeletal disorder characterized by defective structures of vertebral bodies and/or of epiphyses of the long bones, resulting in moderately short stature and early joint degeneration. TRAPPC2 gene, which is important for collagen secretion, has been reported as causative for SEDT-XL.


Case presentation
Here, we report two variants of TRAPPC2 gene of SEDT-XL patients, a missense variant of start codon, c.1A > T, and a deletion variant, c.40delG. To understand molecular consequence of the variants, we establish an in vitro gene expression assay system and demonstrate that both mutated genes are transcribed, but are not properly translated, indicative of the pathogenic nature of those TRAPPC2 variants.


Conclusions
In the current study, we provide additional experimental data showing that loss-of-function TRAPPC2 variants are probably causative for SEDT-XL phenotype. These findings further contribute to the understanding the clinical picture related to TRAPPC2 gene.
ko_KR
dc.description.sponsorshipTJC is supported by National Research Foundation (NRF) funded by the Ministry of Science, ICT & Future Planning of the Korean government (NRF2014M3C9A2064684: Genome Technology to Business Translation Program), which has been used for the patient recruitment and care, and determining genetic variants. YK is supported by NRF funded by the Ministry of Science, ICT & Future Planning of the Korean government (NRF-2014M3C9A2064688: Genome Technology to Business Translation Program and RF2016R1A5A1011974), which have been used for validation of the pathogenicity of identified variants and in vitro functional studies. All the decisions regarding to the current studies are made by authors, not by funders. The funders are not involved in the study design, data collection and analysis, performing experiments and in writing the manuscript.ko_KR
dc.language.isokoko_KR
dc.subjectX-linked spondyloepiphyseal dysplasia tardako_KR
dc.subjectTRAPPC2ko_KR
dc.subjectSkeletal dysplasiako_KR
dc.subjectGene expressionko_KR
dc.titleNovel loss-of-function variants of TRAPPC2 manifesting X-linked spondyloepiphyseal dysplasia tarda: report of two casesko_KR
dc.typeArticleko_KR
dc.contributor.AlternativeAuthor원준연-
dc.contributor.AlternativeAuthor김다연-
dc.contributor.AlternativeAuthor박영-
dc.contributor.AlternativeAuthor이혜란-
dc.contributor.AlternativeAuthor임종석-
dc.contributor.AlternativeAuthor박종훈-
dc.contributor.AlternativeAuthor송미현-
dc.contributor.AlternativeAuthor송해령-
dc.contributor.AlternativeAuthor김옥화-
dc.contributor.AlternativeAuthor김용환-
dc.contributor.AlternativeAuthor조태준-
dc.identifier.doi10.1186/s12881-019-0802-2-
dc.language.rfc3066en-
dc.rights.holderThe Author(s).-
dc.date.updated2019-05-05T03:36:16Z-
Appears in Collections:
Files in This Item:

Altmetrics

Item View & Download Count

  • mendeley

Items in S-Space are protected by copyright, with all rights reserved, unless otherwise indicated.

Share